Insulin is a medicine that can only currently be administered by using syringes and needles. Injecting insulin causes great discomfort for many people, creates a risk of infection and often requires trained health personnel, which is expensive for society. Developing new methods that enable people to take drugs as capsules instead would be significant the people using the medicine and for society. The greatest impediment to success is that many of the important drugs, especially proteins, are not absorbed by the intestines.
“We want to develop new methods in our new centre that can significantly increase the absorption of pharmaceutical proteins in the intestines so that these drugs can be administered to people as tablets or capsules,” says Thomas Lars Andresen.
Thomas Lars Andresen, Professor, Department of Micro- and Nanotechnology, Technical University of Denmark
Tomas Kirchhausen, Professor, Department of Cell Biology, Harvard Medical School, Boston, United States
Chris Porter, Professor, Faculty of Pharmacy and Pharmaceutical Sciences, Monash Institute of Pharmaceutical Sciences, Monash University, Australia
Nazila Kamaly, Associate Professor, Department of Micro- and Nanotechnology, Technical University of Denmark
Henrik Flyvbjerg, Associate Professor, Department of Micro- and Nanotechnology, Technical University of Denmark
Wayne Lencer, Professor, Department of Cell Biology, Harvard Medical School, Boston, United States
